HCA Healthcare, Inc.
Thesis
HCA is presented as an attractive investment opportunity due to its position as the largest hospital operator in the US, with a strong market presence that allows for favorable negotiations with insurers and significant cost advantages. The company is expected to benefit from demographic trends and healthcare reforms, with a potential upside of 75% over the next three years, while also having the capacity to buy back a substantial portion of its shares.
Did it work?
The thesis targets roughly 75% upside over three years, but no price performance data is available and the time elapsed since the pitch is unknown, so the return cannot be weighed against the stated horizon. There is also no information confirming or refuting the thesis's key drivers (insurer negotiation leverage, demographic tailwinds, buyback execution). Without either price evidence or verified thesis events, no verdict on success or failure is possible.